Deal watch : BMS acquires rights for IL-6 inhibitor.
- Published in:
- 2010
- Publication type:
- journal article
Works matching DE "ALDER BioPharmaceuticals Inc."
Results: 2
1
2
Migraine mAbs crowd into late-stage trials.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 7, p. 676, doi. 10.1038/nbt0715-676c
- By:
- Publication type:
- Article